Keio University

Press Release

191-200 items (total 448)
Published At January 14, 2022

Hydrogen Suppresses NETs Production by Activated Neutrophils and Improves Inflammatory Response

Published At January 14, 2022

Clinical Study of "Regenerative Medicine Using iPS Cell-Derived Neural Progenitor Cells for Subacute Spinal Cord Injury" (Cell Transplantation Performed on the First Patient)

Published At January 11, 2022

Mechanism That Prevents Autoimmune Diseases from Attacking the Body's Own Tissues Elucidated in Peripheral Tissues Such as the Skin

Published At December 24, 2021

Elucidating the Entire Process of Skin Regeneration in Newts: A Step Toward Regenerative Treatment for Scar-Free Healing

Published At December 24, 2021

Expanded Health Insurance Coverage for Anti-CD20 Monoclonal Antibody (Rituximab) Therapy for Refractory Pemphigus—Regulatory Approval Based on an Investigator-Initiated, Multicenter, Collaborative Clinical Trial Led by Keio University Hospital

Published At December 23, 2021

World's First Successful Transplantation Experiment Using a Near Human-Sized Bio-Artificial Liver—Accelerating the Realization of Organ Regenerative Medicine—

Published At December 21, 2021

Launch of a Study on the Effectiveness of COVID-19 Workplace Vaccinations

Published At December 13, 2021

The 6th Keio Healthcare Venture Contest to be Held - Aiming to Create 100 Start-ups from the Keio University School of Medicine -

Published At December 09, 2021

Elucidating the Pathogenesis of Gastrointestinal Neuroendocrine Carcinoma through Comprehensive Genomic Analysis, Including Whole-Genome Sequencing—A World-First in Unraveling the True Nature of This Formidable Cancer, with Hopes of Promoting Drug Development—

Published At November 24, 2021

Successful Improvement of Therapeutic Effects for Spinal Cord Injury by Stimulating Transplanted Human iPS-Derived Cells: Enhancement of Synaptic Activity through Selective Cell Stimulation Using Artificial Receptor Technology